#TODAY FDA Warns Novo Nordisk of Unreported GLP-1 Side Effects

FDA Warns Novo Nordisk of Unreported GLP-1 Side Effects
The Food and Drug Administration issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side effects in patients who took its blockbuster medications.

Thank you for your support in keeping this website running.💛

View on “Tokyo Trend News”